Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Appointments

Executives On The Move: New Arrivals In Commercial For Exopharm And Primex, And A Departure At Grupo Biotoscana

For Exopharm, an Australian regenerative medicine firm, a new chief commercial officer, and for Primex Pharmaceuticals, a global anesthesia products company, a new head, global commercial. Over at Latin American advanced medicines business Grupo Biotoscana, a CEO resignation.

Appointments BioPharmaceutical

Executives On The Move: Financial Promotions To C-Suite Spots At Gilead and Amgen, And A VP Exits GSK For Achilles

Next month a promotion from EVP, development to CFO will take place at Gilead Sciences, and in the new year an EVP, Finance will assume the CFO spot at Amgen. Meanwhile, a VP will exit GSK to be CBO at personalized T-cell therapy firm Achilles Therapeutics.

Appointments BioPharmaceutical

Executives On The Move: Development Hires At BiomX And CytomX, Revance Chooses a CEO

Two new chief development officers: former Teva Pharma exec moves to microbiome-based therapeutics firm BiomX; and BioGene CMO makes a change to oncology biopharma CytomX. At Revance Therapeutics, a developer of therapeutic neuromodulators, a CEO is chosen.

Appointments BioPharmaceutical

Asia Executives On The Move: Senior Changes At Biogen, Amicus, PhRMA In Japan, Ascletis and Lupin

The coming of autumn ushers in a flurry of executive changes. Biogen has a new R&D head for Japan while Amicus Japan has a  new president, and other executive changes take place at Ascletis, Lupin and industry trade groups PhRMA and IPA.
Appointments Japan

Executives On The Move: Everest Poaches From Big Pharma; Gilead Gets New CMO

China and Asia-focused Everest Medicines has poached a handful of senior hires from Sanofi, Abbott and Amgen, while Gilead Sciences’ new chief medical officer Merdad Parsey joins from Genentech.

Appointments BioPharmaceutical

Executives On The Move: New Leaders Fill C-Suite Positions At Midatech, Retrophin And Sangamo

Midatech Pharma and Retrophin – both developing therapies for rare diseases – appoint CFO and chief commercial officer, respectively. Meanwhile, genomic medicine company Sangamo Therapeutics hires a CMO.

Appointments BioPharmaceutical

Executives On The Move: Regional And Global Position Changes At SIFI, EMD Serono And Acino

EMD Serono welcomes SVP, North American medical affairs while ophthalmic products company SIFI SpA announces country manager, Italy and. At Acino International a new global head for IT is now on board.

Appointments BioPharmaceutical

Asia Executives On The Move: Senior Level Changes At Pfizer Upjohn, Simcere In China

The change of seasons sees a flurry of senior level executive changes taking place across the Asia Pacific health sector. Appointments include a new GM at Pfizer Upjohn China while Sanofi Japan has a new specialty business head and Lupin changes its US head. 
Appointments Asia Pacific

Executives On The Move: Menarini Group Chooses Next CEO, Crescendo Decides On A CBO And Scholar Rock Adds Head, Medical Research

At Italian Biopharma Menarini Group a former Merck KGaA head of new business is now CEO. Oncology therapeutics firm Crescendo Biologics picks GSK exec as CBO and Biogen medical director is now a Medical Research Head at clinical-stage biopharma Scholar Rock.

Appointments BioPharmaceutical

Executives On The Move: New CEOs at RhoVac and Step Pharma

Recent appointments at executive level in pharmaceutical and biotech companies include new CEOs at RhoVac AB, Step Pharma and Ascendis Health, a new chief business officer at MaaT Pharma, and a new chief scientific officer at Pieris Pharmaceuticals.


Appointments BioPharmaceutical

Executives On The Move: Bayer Acquires Talent from J&J And Synlogic And Stealth Decide On Chief Positions

Former J&J exec joins Bayer AG as head, business development and licensing. Synthetic biotic medicines firm Synlogic welcomes a CMO and Stealth BioTherapeutics, which is developing candidates for treatment of mitochondrial dysfunction, adds a CFO.

Appointments BioPharmaceutical

Executives On The Move: Management Changes In Quality, Tech And Finance At Eisai, Frequency Therapeutics And Fresenius

Japanese pharma Eisai picks Merck Research exec as VP, Global Clinical Quality Assurance and former Moderna scientist joins regenerative med company Frequency Therapeutics in SVP, Technology Development slot.  Meanwhile, Fresenius Medical Care announces CFO hire.

Appointments BioPharmaceutical
See All